Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905718-21-001428
Filing Date
2021-11-04
Accepted
2021-11-03 17:31:07
Documents
2
Group Members
COMMODORE CAPITAL MASTER LP

Document Format Files

Seq Description Document Type Size
1 SC 13G cogentbio_13goct72021.htm SC 13G 49387
2 JOINT FILING AGREEMENT cogentbio_13goct72021ex1.htm EX-1 4407
  Complete submission text file 0000905718-21-001428.txt   55552
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Subject) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90431 | Film No.: 211376772
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153 917-970-1730
COMMODORE CAPITAL LP (Filed by) CIK: 0001831942 (see all company filings)

EIN.: 832659606 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G